Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24919146 | 1.00 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL24919503 | 0.98 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL25534198 | 0.98 | S1PR5 (0.33) | S1PR5S1PR4 | |
| SCHEMBL23224700 | 0.96 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL24919358 | 0.96 | S1PR5 (0.33) | S1PR5S1PR4 | |
| SCHEMBL23179625 | 0.95 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL23180702 | 0.95 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL24918628 | 0.94 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL25534152 | 0.94 | S1PR5 (0.32) | S1PR5S1PR4 | |
| SCHEMBL23179646 | 0.94 | S1PR5 (0.33) | S1PR5S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-01 | — | — | US | disclosed |
| US-20170151355-A1 | TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172058-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, PIEZO1, ELAVL1 | S1PR5 4533/4885S1PR4 3989/4885 |
| US-20170151355-A1 | TARGETED RADIOLABELED COMPOUNDS AND THEIR USE FOR THE TREATMENT AND DIAGNOSIS OF CANCER | NTPCR, TYMP, DUT | S1PR5 778/4885S1PR4 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.